Completed PHASE4 INTERVENTIONAL NCT00504764

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

APL-R2007: Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

Sponsor: PETHEMA Foundation

Interventions ATRA Allogenic Transplantation Arsenic Trioxide Autologous Transplantation

Updated 6 times since 2017 Last updated: Oct 27, 2014 Started: Jul 31, 2007 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00504764, this PHASE4 trial focuses on Acute Promyelocytic Leukemia and remains completed. Sponsored by PETHEMA Foundation, it has been updated 6 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PETHEMA Foundation

Data source: PETHEMA Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Albacete, Spain , Alcorcón, Spain , Alicante, Spain , Alzira, Spain , Badalona, Spain , Barcelona, Spain , Basurto, Spain , Bilbao, Spain , Cadiz, Spain and 51 more locations